updated: Sep 6, 2022 14:23 EDT
MENLO PARK, Calif., September 6, 2022 (Newswire.com)
Earlens, a privately held medical technology company transforming the way people hear with a new class of non-surgical hearing technology, supports the FDA’s ruling to create a new category of Over the Counter (OTC) hearing aids. Hearing loss, a medical epidemic associated with dementia, depression and social isolation, affects an estimated 30 million people in the United States. Despite the high prevalence and public health impact of hearing loss, only about one-fifth of people who could benefit from a hearing aid seek intervention.
While this new ruling may address a few of the barriers that impede…